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Abstract 
           Background and Objectives: Asthma and obesity have a 
considerable impact on public health and their prevalence has increased in 
recent years. The association between asthma severity and obesity has been 
increasingly established. The objective of this present study is to confirm the 
relationship between asthma severity and body mass index or obesity. 
Patients and Methods: This cross sectional descriptive study was 
conducted at Allergy and Asthma center and Sulaimani Internal Teaching 
Hospital. One hundred patients (66 female and 34 male), aged between 16 -
79 years old who were previously diagnosed with asthma were included in 
this study. US dietary guideline was used to categorize body mass index 
groups. Asthma severity was classified according to the criteria of the global 
initiative for asthma guidelines in 2008. Statistical package for social 
science (version 21) was used for statistical analysis. 
Results: The mean + standard deviation of body mass index and global 
initiative of asthma for asthma severity classification were 28.8 + 7.3 and 
4.1 + 1.1, respectively. The positive correlation coefficient was found 
between body mass index and asthma severity classification of global 
Initiative for Asthma (r=0.252). Therefore, this positive correlation was 
statistically significant (p=0.011) independent on sex and ages .The 
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coefficient of body mass index was 0.035. Thus, this means that for one 
value increase in body mass index, a 3.5% increase in Asthma severity class 
would be expected. 
Conclusion: Obesity was positively correlated with asthma severity. This 
correlation suggests that obesity may be a potential modifiable risk factor 
for asthma exacerbation. 
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Introduction  
        Asthma is one of the most common chronic lung diseases worldwide. It 
is characterized by recurrent respiratory symptoms, especially wheezing, 
shortness of breath, chest tightness, and coughing.  These symptoms differ 
in intensity  from person to person, and also wax and wane over time 
(Global asthma day, 2014). Asthma predominantly occurs in boys during 
childhood with a male-to-female ratio of 2:1. At puberty, the male-to-female 
ratio becomes 1:1; but after puberty, the asthma prevalence is greater in 
female compared to males (Burrows et al., 1999). Consequently, asthma has 
affected an estimated 300 million individuals worldwide. It is estimated that 
there may be an additional 100 million persons with asthma by year 2025. 
Also, it is worth mentioning that the World Health Organization has 
estimated that annually, 15 million disability-adjusted life-years were lost 
and 250,000 asthma deaths were reported worldwide (Masoli et al., 2004). 
The pathophysiology of asthma is complex and involves the following 
components: Airway inflammation, intermittent airflow obstruction, and 
bronchial hyper-responsiveness (National Heart, Lung, and Blood Institute, 
May 2008).  
 
Diagnosis of Asthma 
 The diagnosis of asthma is based on clinical symptoms, physical 
examination, and pulmonary function test (Gjevre et al., 2006). Spirometry 
is recommended as the ideal method to establish a diagnosis of asthma. 
Improvements in Forced expiratory volume in first second (FEV1) within 10 
minutes after inhalation of rapid-acting bronchodilator or reversibility in 
FEV1 indicates that a diagnosis of asthma is accepted as >12% (or >200ml) 
from pre-bronchodilator.  Also, Peak Expiratory Flow (PEF) measurements 
can be an important aid in the diagnosis and monitoring of asthma. 
Therefore, PEF should be measured first in the morning before treatment is 
taken, when values are at their lowest, and lastly at night when values are 
usually higher. A 60 L/min (or >20% of pre-bronchodilator PEF) 
improvement after inhalation of a bronchodilator or a diurnal variation in 
PEF >20% suggests a diagnosis of asthma (Holohan et al., 2012). 
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Asthma Severity 
       The severity of asthma was classified according to the criteria of the 
2008 global initiative for asthma (GINA). However, they are classified as 
intermittent, mild persistent, moderate persistent, and severe persistent.  
 Table 1. Steps of GINA classification 
 
Treatment of Asthma 
Stepwise Pharmacologic Therapy                                                                                               
       Asthma medications should be added or deleted as the frequency and 
severity of the patient's symptoms changes (Global Strategy for Asthma 
Management and Prevention, 2014). 
 Steps 1 - Intermittent Asthma:  A controller medication is not 
indicated. The reliever medication such as SABA is needed for symptoms.                                                                  
 Step 2 - Mild Persistent Asthma:  Controller medication is a low-
dose ICS. Alternatives include sodium cromolyn, nedocromil, and 
leukotriene receptor antagonist (LTRA)(Berridge, 2000) . 
 Step 3 - Moderate Persistent Asthma:  Controller medication is 
either a low-dose ICS plus a LABA (combination medication preferred 
choice to improve compliance)(Nelson, 2001) or a medium-dose ICS. 
Alternatives include a low-dose ICS plus either a LTRA, theophylline, or 
zileuton. 
 Step 4 - Moderate-to-Severe Persistent Asthma: Controller 
medication is a medium-dose ICS plus a LTRA (combination therapy). 
Alternatives include medium-dose ICS plus either a LTRA, theophylline, or 
zileuton. 
  Symptoms/Day Symptoms/Night PEF or 
FEV1 
PEF 
Variability 
STEP 1 
Intermittent 
< 1 time a week 
 
Asymptomatic and 
normal PEF 
between attacks 
</= 2 times a 
month 
  
>/= 80% 
  
< 20% 
  
STEP 2 
Mild Persistent 
> 1 time a week but 
< 1 time a day 
 
Attacks may affect 
activity 
> 2 times a 
month 
  
>/= 80% 
  
20-30% 
  
STEP 3 
Moderate Persistent 
Daily 
 
Attacks affect 
activity 
> 1 time a week 
  
60%-80% 
  
> 30% 
  
STEP 4 
Severe Persistent 
Continuous 
 
Limited physical 
activity 
Frequent 
  
</= 60% 
  
> 30% 
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 Step 5 - Severe Persistent Asthma: Controller medication is a high-
dose ICS plus LTRA. 
 Step 6 - Severe Persistent Asthma: Controller medication is a high-
dose ICS plus a LTRA plus an oral corticosteroid (National Heart, Lung, 
and Blood Institute, May 2008). 
 Anti IgE: Omalizumab is indicated for moderate-to-severe persistent 
asthma in patients with a positive skin test and symptoms that are 
inadequately controlled with inhaled corticosteroids. However, it is given 
subcutaneously every (2-4) week. It determines the precise dose and 
frequency by total IgE level and body weight measured before starting 
therapy, and then periodically (Marcus, 2006). 
  
Obesity 
       It is often defined as excess body weight rather than as excess body 
fat. BMI is calculated as weight in kilograms divided by the height in meters 
squared (Dietz, 1999; Keys, 1972).  Healthy weight is defined as a BMI of 
18.5 up to 24.9, overweight is defined as a BMI of 25 up to 29.9, and 
obesity is defined as a BMI of 30 or greater by the United States Dietary 
Guidelines (Dietary for Americans, 2005). Currently, it is estimated that 97 
million adults in the United States are overweight (Flegal, 1998). 
 
 Relation between Asthma and Obesity 
       Both asthma and obesity are important health problems worldwide. 
Subsequently, their prevalence has widely increased over the past decade 
(Maalej, 2012). During the last 3 decades, the incidences of both obesity and 
asthma have shown a steady rise, with the incidence of asthma which has 
tripled more during this period (Flegal, 1998). Obesity could affect asthma in 
two ways.  First, the release by adipocytes of various pro-inflammatory 
cytokines and mediators such as Interleukin 6(IL6) (Rowe, 2004). 
Furthermore, this could induce airway inflammation or increase its severity. 
Also, it will contribute to airway hyper-responsiveness. Second, the pressure 
of the increased tissue mass in the chest wall and abdomen has a direct 
mechanical effect on the lungs, which could modify airway hyper-
responsiveness or could increase symptoms (Farah, 2012) . So obesity can 
reduce lung compliance and lung volumes, and can disturb the ventilation-
perfusion relationship (Juel, 2013). 
 
Objectives 
 To determine the severity of asthma among studied groups, and to 
assess the relationship between the severity of asthma and BMI. 
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Patients and Method 
  Cross sectional descriptive study was conducted in Sulaimani 
Internal Teaching Hospital, and Allergy and Asthma center from January 
2014 to April 2014. One hundred patients were included in this study. 66 
were female and 34 were males. 67 patients were from Allergy and Asthma 
center, while 33 were from Internal Teaching Hospital. All patients had 
special questionnaire form filled with detailed socio-demographic 
information. Therefore, all of them had BMI calculated by the following 
equation: BMI= weight (kg)/ height (m) 2. Patients were considered to be 
obese if BMI was equal or  greater than 30 kg/m2, and over-weight if BMI 
of 25 is up to 29.9 (Marcus, 2006; Dietz, 1999; Keys, 1972). 
 Asthma severity was defined by using the criteria of the 2008 GINA 
guidelines.  These guidelines categorize asthma severity into four categories 
based on clinical symptoms, physical activity, and pulmonary function test 
(FEV1or PEF) (Maalej, 2012). 
 All had standard spirometry (Jaeger Tonnes, version 4.3, 
Medizintechnikmit system) and it was conducted in the respiratory 
laboratory by a trained respiratory technician on the day of the patient’s 
visit. 
 Collected data were entered into excel sheet program. Data cleaning 
process were conducted for variables, and the data were then transferred to 
Statistical Package of Social Science (SPSS). SPSS software version 21 was 
used for all statistical analysis. In addition, P value <0.05 was considered to 
be significant. 
 
Ethical Consideration 
 Scientific committee accepted selected topic. Also, official 
acceptance was taken from health authorities to conduct this study. 
Furthermore, the aim of study was made clear to all participants, and 
information collected was kept confidential. 
 
Results 
 The mean age of the studied sample was 45 years old. However, the 
minimum age is 16 and the maximum age is 79 years old. Also, the mean of 
BMI was 29.07 with a maximum BMI of 57.5 and a minimum BMI of 16.7. 
Table 2. Age, duration of smoking, and BMI distribution of studied sample 
Studied Variables Minimum Maximum Mean Std. Deviation 
Age (Years) 16 79 45.0 15.53 
Duration of smoking (Years) 1 30 13.0 8.78 
BMI 16.7 57.5 29.07 6.73 
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 Total numbers of the patients were 100 (34 males 66 females). 67% 
were inside the city, 69% were unemployed, nearly quarter of them had low 
income, 36% were illiterate, and 5% of them had university degree. Nearly 
half of them were never smoking and had no family history of asthma 
(Table 3). 
Table 3. Socio-demographic characteristics of the studied sample 
 
 Nearly half of the studied group were reported as a severe persistent 
class of GINA classification, while minority were reported as remission 
class (2%) (Figure1). 
Socio-demographic Characteristics Frequencies Percentages 
Sex 
Male 
Female 
Total 
34 
66 
100 
34.0 
66.0 
100.0 
Residence 
Inside city 
Outside city 
Total 
67 
33 
100 
67.0 
33.0 
100.0 
Occupation 
Unemployed 
Employed (Official) 
Total 
69 
31 
100 
69.0 
31.0 
100.0 
Income 
Good 
Average 
Low 
Total 
29 
44 
27 
100 
29.0 
44.0 
27.0 
100.0 
Educational level 
Illiterate 
Primary 
Secondary 
Preparatory 
Institute 
University 
Total 
36 
26 
14 
11 
8 
5 
100 
36.0 
26.0 
14.0 
11.0 
8.0 
5.0 
100.0 
Smoking history 
Current 
Ex-smoker 
Social 
Passive 
Never 
Total 
3 
16 
7 
20 
54 
100 
3.0 
16.0 
7.0 
20.0 
54.0 
100.0 
Family history of Asthma 
Yes 
No 
Don't know 
Total 
37 
55 
8 
100 
37.0 
55.0 
8.0 
100.0 
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Figure 1. Frequency distribution of GINA class among studied sample 
 
      Approximately half of the studied samples were obese, quarter of them 
were over-weight, and only 2% were under weight (Figure 2).   
            Figure 2. Frequency of different BMI groups among studied sample. 
 
          Approximately, 50% of the studied samples were allocated in severe 
persistent asthma (figure 1); 45% of the studied samples were obese (figure 
2); and most of the obese patients were reported to have severe persistent 
asthma. There were two underweight patients among the studied sample 
(figure 2) which were also allocated to severe persistent class (figure 3).  
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Figure 3.  Frequency of BMI groups with GINA severity class 
  
 The mean + SD of BMI and GINA severity class of asthma were 28.8 
+ 7.3 and 4.1 + 1.1, respectively. The spearman’s correlation coefficient 
analysis was carried out to test the relationship between BMI and GINA 
severity class of asthma. A positive correlation was found between BMI and 
GINA severity class of asthma (r=0.252). This positive correlation was 
statistically significant (P<0.05) as shown in Table (3) and figure (3). This 
relationship indicates that when the BMI increases, the GINA severity class 
of asthma will increase. 
 Table 4. Correlation between BMI and GINA severity class of asthma 
 
      The scatter plot of asthma severity increased in the studied samples 
when the BMI increased (Figure 4). 
       According to regression analysis, the effect of BMI on GINA class was 
significant (P=0.016). The coefficient of the BMI effect was positive 
(β=0.035, 95% CI of β=0.007 to 0.064), indicating that the greater value of 
BMI are causing higher GINA severity class of asthma. The coefficient of 
BMI was 0.035. This means one value increase in BMI would result to a 
3.5% increase in GINA severity class of asthma. Thus, this percentage of 
increase ranges from 0.7% to 6.4% (Table 5). 
 Speareman’s Correlation Coefficient P Value 
BMI  
0.252 
 
0.011 Asthma (GINA severity class) 
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   Figure 4. Scatter plot distributions of the correlation between BMI and GINA severity 
class. 
 
Table 5. Regression analysis of BMI and GINA severity class of asthma 
 
Discussion 
       In recent years, an increase in prevalence of both asthma and obesity 
has been observed. Many studies and trials have been conducted for this 
purpose. Hence, most of them suggested that there is a relationship between 
severity of asthma and obesity. The present study had evaluated the impact 
of obesity on asthma and has demonstrated a positive correlation. That is to 
say that obesity increases severity of asthma. This positive correlation was 
statistically significant (p=0.011). Therefore, one value increase in BMI 
would result to a 3.5% increase in GINA severity class. A possible 
explanation for that positive correlation is that both obesity and asthma can 
cause excessive small airway obstruction which increase asthma severity in 
those with high BMI. Majority of the obese patients were allocated in severe 
persistent asthma class, and the two under-weight patients included in the 
studied samples were also allocated in severe persistent asthma. 
 
Unstandardized 
Coefficients 
Sig. 
95.0% Confidence Interval for 
B 
B Std. Error Lower  Upper  
 BMI 0.035 .014 0.016 0.007 0.064 
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Consequently, this may be explained by other factors that influence the 
severity of asthma other than obesity. 
       Many studies up till date had demonstrated an association between 
obesity and increased asthma severity in adults (Akerman, 2004; Saint-
Pierre, 2006; Varraso, 2005). They demonstrated an increased likelihood of 
obesity among adults with both moderate and severe persistent asthma 
compared with adults with mild intermittent asthma (Akerman, 2004). 
Similarly, Saint-Pierre et al demonstrated that patients with severe persistent 
asthma were more likely to be overweight (defined as BMI >25) compared 
with those with mild persistent and moderate persistent asthma (Saint-
Pierre, 2006) 
       Subsequently, other studies have failed to demonstrate associations 
between obesity and asthma severity (de Marco et al., 2006; Conley-
Thomson, 2003; Chinn, 2002). Hence, they showed no difference in 
baseline BMI across asthma severity groups using GINA severity 
classification (de Marco et al., 2006). 
       Moreover, Conley-Thomson C et al and Chinn S et al revealed no 
significant sex differences in the relationship between BMI and asthma 
severity (Conley-Thomson, 2003; Chinn, 2002). Other studies found that this 
association was significant among women but not among men (Juniper, 
1999; Chanez, 2006;  Dixon, 2006). 
       Consistent with this present study, Mosen et al found that smoking 
had no significant value (Mosen, 2008). Also, Maalej S. et al showed that 
obese smokers were significantly more likely to have a more severe asthma 
(Maalej, 2012). 
       Also, similar finding of this present study was observed in a study 
conducted by B Taylor et al. Thus, their study found no significant value of 
positive family history of asthma with BMI and severity class (p= 0.92) 
(Taylor, 2008). 
 
Conclusion 
 This study confirmed that the severity of asthma increases with 
rising in the prevalence of obesity in adult patients.  
 Age and sex were not associated with asthma severity and BMI. 
 Smoking had no significant effect on the relation of asthma severity 
and BMI. 
 
References: 
Global asthma day: Global Strategy for Asthma Management and 
Prevention Media Backgrounder (May 2014). Retrieved from 
http://www.ginasthma.org/ local/ uploads/ content/files/Strategy 
Backgrounder.pdf. 
European Scientific Journal December 2015 edition vol.11, No.36 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
203 
Burrows, B., Barbee, R.A., Cline, M.G., Knudson, R. J., and Lebowitz, M. 
D. (1999). Characteristics of asthma among elderly adults in a sample of the 
general population. Chest, 100(4), 935-42. 
Masoli, M., Fabian, D., Holt, S., and Beasley, R. ( 2004). Global Initiative 
for Asthma (GINA) Program: The global burden of asthma: executive 
summary of the GINA Dissemination Committee report. Allergy, 59(5),469-
478. 
National Heart, Lung, and Blood Institute. (May 2008). Global Strategy for 
Asthma Management and Prevention. Retrieved from  
http://emedicine.medscape.com/article/296301-overview#aw2aab6b2b4. 
Gjevre, J.A. , Hurst, T.S., Taylor-Gjevre, R.M., and Cockcroft,  D.W. 
(2006). The American Thoracic Society's spirometric criteria alone is 
inadequate in asthma diagnosis. Can Respir J , 13(8), 433–37. 
Holohan,  J., Mannig, P. , and Nolon, D. (2012).  Asthma control in general 
practice: Adopted from the GINA global strategy for asthma management 
and prevention. 2nded. Quality in practice committee; 1-15 
Maalej, S., Yaacoub,  Z., Fakhfekh,  R.,  Yaalaoui, S., Kheder, A., and 
Drira, I. (2012). Association of Obesity with Asthma Severity, Control and 
Quality of  life. Tanaffos , 11(1), 38-43. 
Global Strategy for Asthma Management and Prevention, Global Initiative 
for Asthma (GINA) (2014). Retrieved from http://www.ginasthma.org . 
Rowe, B.H., Edmonds, M.L., Spooner, C.H., Diner, B., and Camargo, C.A. 
(2004). Corticosteroid therapy for acute asthma. Respir Med , 98(4), 275-84. 
Expert Panel Report: Guidelines for the Diagnosis and Management of 
Asthma-Summary Report (2007).  J Allergy ClinImmunol, 120(5Suppl), 
S94-138. Retrieved from 
http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf. 
Global Strategy for Asthma Management and Prevention, Global Initiative 
for Asthma (GINA) (2010). Retrieved from http://www.ginasthma.org. 
Berridge, M.S., Lee, Z., and Heald, D, L. (2000). Pulmonary distribution 
and kinetics of inhaled [11C] triamcinoloneacetonide. J Nucl Med , 41(10), 
1603-11. 
Nelson, H.S. (2001). Combination treatment with fluticasone 
propionate/salmeteroli 
the treatment of asthma.  J Allergy ClinImmunol, 107(2), 398-416. 
Marcus, P.(2006). Incorporating anti-IgE (omalizumab) therapy into 
pulmonary medicine practice: practice management implication. Chest, 129, 
466-74. 
Dietz, W.H.,  and Robinson, T.N. (1998). Use of the body mass index (BMI) 
as a measure of overweight in children and adolescents. J Pediatr , 132, 
191–93. 
European Scientific Journal December 2015 edition vol.11, No.36 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
204 
Keys, A., Fidanza, F., Karvonen, M.J., Kimura, N., and Taylor, H.L. (1972).  
Indices of relative weight and obesity.  J Chronic Dis , 25, 329–43. 
U.S. Department of Health and Human Services and U.S. Department of 
Agriculture. Dietary for Americans (2005). Retrieved from: 
http://www.health.gov/dietaryguidelines/. 
Flegal, K.M., Carroll, M.D., Kuczmarski, R.J., and Johnson, C.L. (1998). 
Overweight and obesity in the United States: prevalence and trends, 1960–
1994. IntObesRelatMetabDisord , 22(1), 39-47. 
From the Global Strategy for Asthma Management and Prevention, Global 
Initiative for Asthma (GINA). (2011) . Retrieved from 
http://www.ginasthma.org. 
Farah, C.S., and Salome, C.M. (2012). Asthma and obesity: A known 
association but unknown mechanism.  Respirology, 17, 412–21. 
Juel,  C.T. , and Ulrik,  C,S. (2013). Obesity and Asthma: Imp 21. JuelCT 
,Ulrik  CS. Obesity and Asthma: Impact on Severity Asthma  Control, and 
Response to Therapy.  Respiratory care , 58, 867-71. 
Akerman, M.J., Calacanis, C.M., and Madsen, M.K. (2004). Relationship 
between asthma severity and obesity.  J Asthma , 41, 521–6. 
Saint-Pierre, P., Bourdin, A., Chanez, P., Daures, J.P., and  Godard, P. 
(2006). Are overweight asthmatics more difficult to control?.  Allergy , 61, 
79–84. 
Varraso, R., Siroux, V., Maccario, Pin, I., Kauffmann, F.  (2005). Asthma 
severity is associated with body mass index and early menarche in women. 
Am J RespirCrit Care ed , 171, 334–9. 
de Marco, R., Marcon A, Jarvis D, Accordini, S., Almar, E., Bugiani, M., 
Janson,S.  (2006). Prognostic factors of asthma severity: a 9- year 
international prospective cohort study. J Allergy ClinImmunol, 117, 1249–
56. 
Conley-Thomson, C., Clark,  S., and Carmago, C.A. (2003). Body mass 
index and asthma severity among adults presenting to the emergency 
department. Chest, 124, 795–802. 
Chinn, S., Jarvis, P., and Burney, P. (2002). Relation of bronchial 
responsiveness 
to body mass index in the ECRHS. Thorax, 57, 1028–33. 
Juniper, E.F., O'Byrne,  P.M.,  Guyatt, G.H., Ferrie, P.J., and Kin, D.R. 
(1999). Development and validation of a questionnaire to measure asthma 
control. EurRespir J, 14 (4), 902- 7. 
Chanez, P., Varin, P., Bourdin, A. (2006). Body mass index (BMI) 
discriminates patients with severe asthma.  Proc Am ThoracSoc, 3, A790. 
Dixon, A.E., Shade, D.M., Cohen, R.I., Skloot, G.S., Holbrook, J.T., 
…Smith,  L.J. (2006).  Effect of obesity on clinical presentation and 
response to treatment in asthma. J Asthma, 43 (7), 553-58. 
European Scientific Journal December 2015 edition vol.11, No.36 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
205 
Mosen, D., Schatz, M., Majid, D., Camargo Jr, C. (2008). The relationship 
between obesity and asthma severity and control in adults. J Allergy 
ClinImmunol, 122(3), 507-511. 
32. Taylor, B., Mannino, D., Brown, C., Crocker, D., Twum-Baah, N.,  and 
Holguin, F. (2008). Body mass index and asthma severity in the National 
Asthma Survey. Thorax, 63, 14-20 
 
 
 
 
  
